Annexon Biosciences Competitors and Similar CompaniesClear all

Annexon Biosciences's competitors and similar companies include Metacrine, Vitrolife, Novadip Biosciences and Fulcrum Therapeutics.
Annexon Biosciences
Annexon Biosciences
Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
Metacrine
Metacrine
Targeting Metabolic Disease through Advances in Endocrine Research.
Vitrolife
Vitrolife
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
Novadip Biosciences
Novadip Biosciences
Novadip Biosciences is a biopharmaceutical company.
Fulcrum Therapeutics
Fulcrum Therapeutics
We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
Founding Date
Founding Date
2011
Founding Date
2015
Founding Date
1981
Founding Date
2013
Founding Date
2016
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Brisbane, US HQ
Locations
San Diego, US HQ
San Diego, US
San Diego, US
Locations
Västra Frölunda, SE HQ
Locations
Mont-Saint-Guibert, BE HQ
Locations
Cambridge, US HQ
Employees
Employees
10041% increase
Employees
4
Employees
1,150
Employees
542% increase
Employees
43223% increase
Valuation ($)
Valuation ($)
799.8 m
Valuation ($)
N/A
Valuation ($)
3.1 b
Valuation ($)
N/A
Valuation ($)
202.2 m

Financial

Net income
Net income
($206.7m) (FY, 2025)
Net income
N/A
Net income
(kr5b) (FY, 2025)
Net income
N/A
Net income
($74.9m) (FY, 2025)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 65m (almost 8 years ago)
Latest funding round
N/A
Latest funding round
$ 31.3m (over 10 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 179m
Total funding raised
$ 123m
Total funding raised
N/A
Total funding raised
$ 31.3m
Total funding raised
$ 55m
For sources of this data, please see the company profile

View Company Profiles

Metacrine
HQ
San Diego, US
Employees
4

Targeting Metabolic Disease through Advances in Endocrine Research.

View company
Vitrolife
HQ
Västra Frölunda, SE
Employees
1,150

Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.

View company
Novadip Biosciences
HQ
Mont-Saint-Guibert, BE
Employees
54↑ 2% increase

Novadip Biosciences is a biopharmaceutical company.

View company
Fulcrum Therapeutics
HQ
Cambridge, US
Employees
432↑ 23% increase

We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.

View company